In the research paper titled "Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors to Decrease the Risk of Cardiovascular Diseases: A Systematic Review," the authors collaborated to contribute their expertise in various aspects of the study. This evidence concerns the gene SLC5A2 and cardiovascular disorder.